Covaxin, being developed by Bharat Biotech in collaboration with the
Indian Council of Medical Research and National Institute of Virology,
is now undergoing phase-3 trials. The Phase-3 trials involve 26,000
volunteers across India, conducted in partnership with ICMR.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pm-modi-visits-bharat-biotechs-vaccine-manufacturing-facility-in-hyderabad/articleshow/79462953.cms
No comments:
Post a Comment